Frustrated with low HDR rates in your therapeutic genome editing workflow?
Meet Alt‑C HDR Enhancer Protein
Designed specifically for therapeutic applications and manufactured by Aldevron to meet rigorous quality standards, Alt-C HDR Enhancer Protein is the newest addition to our CRISPR portfolio.
We’ve expertly designed this solution to integrate effortlessly into your existing workflows—empowering a smooth transition from research to clinical development.
Why choose Alt-C HDR Enhancer Protein?
✅Clinical-grade quality—manufactured under CGMP standards
✅Improves HDR efficiency—even in difficult-to-edit cells like iPSCs and HSPCs
✅Maintains cell viability and genomic integrity—no increase in off-target edits, translocations, or cytotoxicity
✅Seamless transition—enabling a smooth move from research to clinic.
Be the first to know when Alt-C HDR Enhancer Protein becomes available by using the link below.
